ARTICLE IN PRESS
G Model TOXLET 8291 1–6
Toxicology Letters xxx (2013) xxx–xxx
Contents lists available at SciVerse ScienceDirect
Toxicology Letters journal homepage: www.elsevier.com/locate/toxlet
Vitamin C forestalls cigarette smoke induced NF-B activation in alveolar epithelial cells
1
2
3 4
Q1
Bannhi Das, Palash C. Maity, Alok K. Sil ∗ Department of Microbiology, University of Calcutta, 35 B. C. Road, Kolkata 700019, India
5
6 7 8 9 10 11
h i g h l i g h t s • • • •
Vitamin C prevents CS-induced nuclear translocation of c-Rel. Vitamin C prevents CS-induced degradation of I-B. Vitamin C prevents CS-induced NF-B activation in alveolar epithelial cells. This activity of vitamin C is conferred by its ROS neutralization ability.
12
13
a r t i c l e
i n f o
a b s t r a c t
14 15 16 17 18
Article history: Received 14 January 2013 Received in revised form 9 April 2013 Accepted 15 April 2013 Available online xxx
19
24
Keywords: Cigarette smoke NF-B Vitamin C Oxidative stress
25
1. Introduction
20 21 22 23
26 27 28 29 30 31 32
Cigarette smoking causes cellular oxidative stress resulting in inflammatory diseases of lung wherein transcription factor NF-B plays an important role. It is possible that vitamin C, an antioxidant, may prevent cigarette smoke (CS)-induced NF-B activation that involves degradation of I-B and nuclear translocation of c-Rel/p50 in alveolar epithelial cells. Therefore, to examine the hypothesis, we verified the effect of vitamin C on CS-induced expression of NF-B driven luciferase reporter and NF-B binding at its target DNA by EMSA in alveolar epithelial A549 cells. We also examined the level of I-B and sub-cellular distribution of c-Rel by western blotting and immunofluorescence respectively in CSE-treated A549 cells with or without vitamin C pretreatment. We observed a significant reduction in CSE induced luciferase expression, NF-B DNA binding, I-B degradation and c-Rel nuclear translocation in cells pretreated with vitamin C. To further validate the result, we examined sub-cellular distribution of c-Rel in lungs of CS-exposed guinea pigs treated or untreated with vitamin C. Result showed that vitamin C treatment resulted in markedly reduced c-Rel nuclear translocation. All these results demonstrate that vitamin C prevents CS(E)-induced NF-B activation and thus it could be used for the prevention of CS-induced inflammatory diseases. © 2013 Published by Elsevier Ireland Ltd.
Cigarette smoke (CS) has been implicated in the initiation and progression of various inflammatory diseases in human lung such as emphysema and cancer (Bhalla et al., 2009; Chiu et al., 2001; Vassallo and Ryu, 2008). The signal transduction pathways triggered by cigarette smoke involves various cellular redox sensitive transcription factor including nuclear factor kappa B (NF-B) (Maity et al., 2012; Tharappel et al., 2010). Transcriptional activator NF-B
Abbreviations: CSE, cigarette smoke extract; CS, cigarette smoke; NF-B, nuclear factor kappa-B; ROS, reactive oxygen species; EMSA, electrophoretic mobility shift assay; FACS, fluorescence activated cell sorter; DCFH-DA, 2 ,7 -dichlorofluorescin diacetate; DCF, 2 ,7 -dichlorofluorescin; DAPI, 4 ,6-diamidino-2-phenylindole; AM, alveolar macrophase; PMN, polymorphonuclear cells. ∗ Corresponding author. Tel.: +91 9831836050. E-mail address:
[email protected] (A.K. Sil).
regulates the expression of genes that plays very important roles in cellular inflammation and inflammatory diseases (Karin et al., 2004; Rahman and Fazal, 2011; Tak and Firestein, 2001). Active NF-B is a hetero/homo dimeric complex consisting of members of the Rel family (p65 (RelA), RelB, c-Rel, p50 and p52). In a resting cell NF-B resides in the cytoplasm in association with inhibitory factor I-B (Hayden and Ghosh, 2004). When cells are activated by various extracellular signals, like tumor necrosis factor alpha (TNF-␣), interleukin-1 ␣, lipopolysaccharide (LPS), I-B is phosphorylated and degraded rapidly. Subsequently, free NF-B dimer enters the nucleus and activates the transcription of many different target genes (Pahl, 1999). The conventional inflammatory stimuli mediated NF-B activation involves degradation of I-B␣ and nuclear translocation of p65/p50 dimer (Ghosh and Karin, 2002). In contrast, in our previous report we have shown a new axis of CS-induced NF-B activation in alveolar epithelial cells wherein the NF-B dimer that translocates to the nucleus is predominantly composed of c-Rel/p50 and this translocation involves degradation
0378-4274/$ – see front matter © 2013 Published by Elsevier Ireland Ltd. http://dx.doi.org/10.1016/j.toxlet.2013.04.009
Please cite this article in press as: Das, B., et al., Vitamin C forestalls cigarette smoke induced NF-B activation in alveolar epithelial cells. Toxicol. Lett. (2013), http://dx.doi.org/10.1016/j.toxlet.2013.04.009
33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
G Model TOXLET 8291 1–6
ARTICLE IN PRESS B. Das et al. / Toxicology Letters xxx (2013) xxx–xxx
2
86
of I-B (Maity et al., 2012). Since NF-B activation plays an important role in inflammation, agents that can block its activation are potentially important for better management of inflammatory diseases caused by CS. CS is a complex mixture of over 4700 chemical compounds, and high concentrations of free radicals and other oxidants. In addition to its contents, CS can also activate intracellular enzymes responsible for generating reactive oxygen species (ROS) thereby leading to cellular oxidative stress. In our previous study we have shown that CS-induced oxidative stress plays an important role in NF-B activation. Therefore, it is likely that an antioxidant like vitamin C, which can effectively scavenge a wide array of ROS and free radicals, can be used to inhibit CS-induced NF-B activation. Vitamin C is a strong antioxidant that maintains a balance of ROS within the cell. Though cells have other antioxidant machinery (e.g., catalase, peroxidase, superoxide dismutase, etc.) to combat the impact of oxidative stress, their level cannot be manipulated by simple means (Frei et al., 1989). However, the importance of vitamin C lies with the fact that this antioxidant is water soluble and it can be easily manipulated by dietary supplementation. In a previous report, Silva Bezerra et al. (2006) demonstrated the effect of vitamin C on the level of alveolar macrophage (AM) and polymorphonuclear cells (PMN) in the lung of CS-exposed mice and in this context they also examined the level of nuclear p65 in lung tissue extract in CS-exposed mice that were either treated or not with vitamin C. They observed that vitamin C treatment resulted in a significant reduction in both the levels of AM and PMN as well as nuclear p65 in lung tissue extracts. However, they did not examine the level of c-Rel, which we observed to be the predominant NF-B component translocated to the nucleus in alveolar epithelial cells. Besides, they have looked at nuclear p65 level in whole lung extract that includes considerable amount of inflammatory cells. Thus the observed nuclear p65 in their experiment may be a major contribution from these inflammatory cells. Therefore we have targeted our efforts to investigate the effect of vitamin C on CS-induced NF-B activation in alveolar epithelial cells.
87
2. Materials and methods
Results are expressed as mean ± standard deviation (SD). Statistical significance between groups was determined using one-way ANOVA and P < 0.01 was considered significant. Statistical analysis was performed using Minitab1 6.
88
2.1. Cell culture and media supplements
3. Results
89
All in vitro experiments were carried out in Human lung alveolar type II cell line A549 grown in (Ham) F12-Nutrient Mixture (Gibco, Invitrogen) supplemented with 10% Fetal Bovine Serum (Gibco, NZ origin), and 100 U/ml penicillin and 100 g/ml streptomycin. A549 cells were transiently transfected with luciferase reporter plasmid construct containing a luciferase gene driven from N F-KB promoter (Promega Inc., E894A) using PolyFect reagent (Qiagen, Hilden, Germany) according to manufacturer’s instruction.
51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85
90 91 92 93 94 95
96
2.2. Preparation of cigarette smoke extract
97 98
Cigarette smoke extract (CSE) were prepared from filter tipped 69 mm cigarette as described previously (Maity et al., 2009).
99
2.3. Electrophoretic mobility shift assay (EMSA)
100
EMSAs were performed using 32 P-labeled oligonucleotide probe containing the consensus sequences for NF-B, according to previously described method (Chaturvedi et al., 2000). DNA-protein complexes were resolved on a nondenaturing 5% polyacrylamide gel and subsequently exposed to either X-ray film (Kodak, Rochester, NY, USA) or phosphor imaging system (Amersham Biosciences, USA).
101 102 103 104 105
106
2.4. Immunofluorescence
107
Immunofluorescence was performed as described previously (Bernard et al., 2002). A549 cells plated on cover slips in 30 mm tissue culture plates were used to study the sub-cellular localization of c-Rel. The cells were differentially treated with CSE and vitamin C (Sigma–Aldrich) as per the requirement of the experiment and then stained with specific antibody against c-Rel (Santa cruz biotechnology). FITC-tagged secondary antibody (Bangalore Genei, India) was used to observe the
108 109 110 111 112
sub-cellular localization of c-Rel. Images were taken using a Fluorescent Microscope (Olympus IX 71, Japan).
113
2.5. Exposure of guinea pigs to CS
115
Three- to four-month-old male guinea pigs (350–400 g) were purchased from University of Calcutta authorized animal supplier. Animal care procedures were as per NIH (National Institutes of Health) guidelines and approved by the Institutional Animal Ethics Committee (University of Calcutta, India). The guinea pigs were fed a vitamin C-free diet for 7 days to minimize the vitamin C level in the plasma and tissues. The composition of the diet was as previously mentioned (Banerjee et al., 2007). After feeding vitamin C-free diet for 7 days, each guinea pig was given oral supplement of 1 mg vitamin C/day as maintenance dose. For experimental purpose one set of animals were given an additional dose of 5 mg vitamin C/day, whereas the control set was supplemented with the normal dose of 1 mg vitamin C/day. All the animals were subjected to CS exposure (three cigarettes/animal/day with two puffs/cigarette) in a smoke chamber (Ray et al., 2010) for 5 days. Guinea pigs were exposed to smoke environment for 1 min during each puff and exposed to fresh air for the next 1 min. For each group, a minimum of 3 animals were used.
116
2.6. Immunohistochemistry
130
Lung tissue from guinea pigs was fixed in formaldehyde and immunohistochemistry was performed as described previously (Maity et al., 2012). Briefly fixed tissue sections were incubated overnight at 4 ◦ C with specific antibodies as per the requirement. Then the sections were incubated with FITC conjugated secondary antibody (Bangalore Genei, India) at room temperature for 2 h, washed and stained with 4 ,6-diamidino-2-phenylindole (DAPI). Fluorescent signals were viewed under fluorescence microscope (Olympus IX71, Japan).
131
2.7. In situ ROS measurement in A549 cells
138
ROS generation in A549 cells was detected by flow cytometric analysis (FACS). A549 cells that were either pretreated or not with vitamin C were treated with CSE for 30 min. After the CSE treatment cells were incubated with 10 M 2 ,7 dichlorofluorescin diacetate (DCFHDA) for 20 min, washed with ice cold PBS and harvested. Next, harvested cells were analyzed for the presence of oxidized 2 ,7 dichlorofluorescin (DGF), by flow cytometer (BD Pharmingen). A total of 10,000 cells were acquired for each sample and the cells were gated out based on their fluorescent property.
139
2.8. Statistics
147
3.1. Effect of vitamin C on CSE-induced transcriptional response mediated by NF-ÄB To investigate the effect of vitamin C on the activation of NFB transcription induced by CSE, a luciferase reporter driven from a promoter containing NF-B binding site was used. A549 transfectants harboring this reporter construct were pretreated with different concentrations of vitamin C for 1 h followed by treatment with 2% CSE for 30 min. A gradual reduction of luciferase activity was observed with the increasing concentration of vitamin C and the maximum reduction was observed for cells pretreated with 100 M vitamin C (Fig. 1A). Henceforth all the subsequent experiments were done with 100 M vitamin C. In order to further confirm the result observed in the luciferase reporter assay EMSA was performed. Nuclear extracts from CSE-treated A549 cells that were either pretreated or untreated with vitamin C were prepared and EMSA was performed as described previously. Congruent with the luciferase assay we observed a marked reduction in the band intensity of NF-B bound DNA complex for the nuclear extract obtained from vitamin C pretreated cells compared to nuclear extract obtained from cells treated with only CSE (Fig. 1B; compare lanes 1 and 3). This result thereby confirms reduced activation of NF-B in vitamin C pretreated cells. Thus both luciferase assay and EMSA demonstrate that pretreatment of alveolar epithelial cells with vitamin C prevents CSE induced N F-B activation.
Please cite this article in press as: Das, B., et al., Vitamin C forestalls cigarette smoke induced NF-ÄB activation in alveolar epithelial cells. Toxicol. Lett. (2013), http://dx.doi.org/10.1016/j.toxlet.2013.04.009
114
117 118 119 120 121 122 123 124 125 126 127 128 129
132 133 134 135 136 137
140 141 142 143 144 145 146
148 149 150
151
152 153
154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
G Model TOXLET 8291 1–6
ARTICLE IN PRESS B. Das et al. / Toxicology Letters xxx (2013) xxx–xxx
3
Fig. 3. Effect of vitamin C on CSE-mediated I-B degradation. A549 cells were pretreated with 100 M vitamin C and then treated with 2% CSE for different time period (as indicated in the figure). Cells were harvested and whole cell extracts were examined for I-B by western blotting. Tubulin was used as loading control.
Fig. 1. Effect of vitamin C on NF-B activation. (A) Effect of vitamin C pretreatment on CS-induced NF-B driven luciferase reporter activity. A549 cells were transiently transfected with a NF-B reporter construct along with a lacZ construct. After 24 h of transfection, cells were pretreated for 1 h with different concentration of vitamin C as indicated in the figure and then treated either with 2% CSE for 30 min or left untreated (control). Cell extracts were prepared and tested for luciferase activity. Results were normalized for transfection efficiencies with respect to beta galactosidase activity. Result represents the mean ± SD of three independent experiments. Mean value with different letters indicate significant difference among different treatments, whereas mean values with same letter indicates no significant difference. P < 0.01 was considered significant. (B) Vitamin C pretreatment reduces DNA binding of NF-B. A549 cells were pre treated with vitamin C and then treated with 2% CSE for 30 min. Nuclear extracts were prepared from the treated cells, and NF-B activation was assayed by EMSA using radiolabeled wild-type NF-B probe. Arrow head indicates DNA bound NF-B complex.
176 177
178 179 180 181 182
3.2. Effect of vitamin C on CSE-induced nuclear translocation of c-Rel in A549 cells In our previous report we have shown that CSE causes nuclear translocation of c-Rel for NF-B activation (Maity et al., 2012). Since vitamin C prevents CSE-induced NF-B activation we investigated whether vitamin C pretreatment can affect the nuclear translocation of c-Rel. To verify this nuclear-cytosolic fractionation was
performed with CSE-treated A549 cells that were either pretreated or left untreated with 100 M vitamin C. As expected, western blot analysis showed that vitamin C prevents nuclear translocation of c-Rel (Fig. 2A, compare lanes 2 and 6). Congruent with the cell fractionation study, the immunofluorescence study showed reduced nuclear accumulation of c-Rel in vitamin C pretreated cells (Fig. 2B). Thus our results demonstrate that vitamin C prevents the nuclear translocation of c-Rel thereby leading to reduced NF-B activity in CSE-treated A549 cells.
3.3. Effect of vitamin C on CSE-induced degradation of I-ÄB in A549 cells CSE-induced NF-B activation in A549 cells requires degradation of I-B (Maity et al., 2012). To get an insight into vitamin C mediated prevention of NF-B activation in CSE treated cells, we investigated the status of I-B in CSE-treated A549 cells that were either pretreated or untreated with 100 M vitamin C. The result showed that pretreatment with vitamin C resulted in marked reduction in CSE-induced degradation of I-B (Fig. 3). Taken together, these observations lead to the conclusion that vitamin C pretreatment leads to decreased degradation of I-B, thereby
Fig. 2. Effect of vitamin C on nuclear translocation of c-Rel. (A) Nuclear cytosolic fractionation. A549 cells were pretreated with 100 M of vitamin C for 1 h and then treated with 2% CSE for 30 min. Nuclear and cytosolic fraction were prepared and separated by SDS-polyacrylamide gel-electrophoresis. Western blot analysis was performed with anti-c-Rel antibody. C and N indicates cytosolic and nuclear fraction respectively. Tubulin and Histone H2B were used as loading controls for cytosolic and nuclear fractions respectively. (B) Immunolocalization. A549 cells were pretreated with vitamin C and then treated with 2% CSE for 30 min, fixed and probed with anti-c-Rel primary antibody.
Please cite this article in press as: Das, B., et al., Vitamin C forestalls cigarette smoke induced NF-B activation in alveolar epithelial cells. Toxicol. Lett. (2013), http://dx.doi.org/10.1016/j.toxlet.2013.04.009
183 184 185 186 187 188 189 190 191
192 193
194 195 196 197 198 199 200 201 202
G Model TOXLET 8291 1–6 4
203 204
205 206
207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224
225 226
227 228 229 230 231
ARTICLE IN PRESS B. Das et al. / Toxicology Letters xxx (2013) xxx–xxx
blocking the nuclear entry of c-Rel ultimately leading to reduced NF-B activation in CSE treated A549 cells. 3.4. Effect of pretreatment of cells with vitamin C on CSE-induced intracellular level of ROS The CS-induced oxidative stress is known to be the major causative agent for the inflammatory effect of cigarette smoke. Vitamin C being an antioxidant is most likely to cause a reduction in the level of cellular ROS and thereby preventing NF-B activation. To verify this we have examined the level of intracellular ROS in CSEtreated A549 cells that were either pretreated or untreated with vitamin C. To determine intracellular ROS, differentially treated A549 cells were stained with the redox sensitive dye DCFH-DA. DCFH-DA is a non-polar compound that readily diffuses into the cells, where it is hydrolyzed to the non-fluorescent polar derivative DCFH and is thereby trapped within the cells. In the presence of ROS, DCFH is oxidized to the highly fluorescent DCF. The presence of oxidized DCF was analyzed by FACS analysis. Consistent with our expectation, the result showed that the treatment of cells with vitamin C resulted in a marked reduction of CSE-induced level of intra cellular ROS (Fig. 4). Therefore, the observed impairment of CS-induced activation of NF-B by vitamin C can be attributed partly if not exclusively to its ability to neutralize cellular ROS. 3.5. Effect of dietary supplement of vitamin C on CS-induced nuclear translocation of c-Rel in guinea pig lung
Fig. 4. Effect of vitamin C on intracellular ROS level in CSE treated A549 cells. Intracellular ROS of control and CSE-treated cells that were either pretreated or not treated with vitamin C was measured by staining with ROS sensitive dye DCFH-DA. The fluorescence resulted from the oxidation of DCFH-DA was analyzed with a flow cytometer (BD Pharmingen, California) using approximately 10,000 cells. The mean fluorescence intensity (MFI) of DCF positive cells was plotted. Result represents the mean ± SD of three independent experiments. Mean value with different letters indicate significant difference among different treatments, whereas mean values with same letter have no significant difference. P < 0.01 was considered significant.
To validate the in vitro results we performed similar experiments in in vivo animal model using guinea pig. For this purpose, guinea pigs were exposed to CS and fed with diet supplemented with or without vitamin C. Thereafter, we looked at the sub-cellular distribution of c-Rel in lung sections of these animals. Consistent
with the in vitro cell culture-based results, immunohistochemical analysis showed marked reduction in nuclear translocation of cRel in lung sections obtained from guinea pigs fed with vitamin C-supplemented diet compared to sections obtained from guinea
Fig. 5. Effect of vitamin C on nuclear translocation of c-Rel in guinea pig lung cells. Sections were made from lungs of CS-exposed guinea pigs that were either provided with vitamin C supplemented diet or not. Localization of c-Rel was carried out by immunohistochemical analysis using anti-c-Rel-antibody and FITC-tagged secondary antibody. Green fluorescence at the top panel indicates the sub-cellular distribution pattern of c-Rel. Panel in the middle shows the DAPI-stained nuclei and the bottom panel represents the merged image of the top and its respective middle panel.
Please cite this article in press as: Das, B., et al., Vitamin C forestalls cigarette smoke induced NF-B activation in alveolar epithelial cells. Toxicol. Lett. (2013), http://dx.doi.org/10.1016/j.toxlet.2013.04.009
232 233 234 235
G Model TOXLET 8291 1–6
ARTICLE IN PRESS B. Das et al. / Toxicology Letters xxx (2013) xxx–xxx
236 237
238
239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292
293
294 295 296
pigs exposed to CS only (Fig. 5). This result clearly lends support to our in vitro study. 4. Discussion A common feature in the pathogenesis of various smoking related diseases is inflammation. Given that NF-B plays a vital role in inflammation, it can be an effective therapeutic target for inflammatory diseases (Karin et al., 2004; Rahman and Fazal, 2011; Tak and Firestein, 2001). Toward this we investigated the role of vitamin C in preventing CS-induced NF-B activation in alveolar epithelial cells. Although inactivation of NF-KB can be achieved by different NF-B inhibitors, the non-specific toxicity of these inhibitors is a major concern (Adams, 2001; Hideshima et al., 2002; Majumdar et al., 2002). On the other hand, vitamin C is nontoxic and pharmacologically safe in dietary consumption. Our results demonstrate that pretreatment of alveolar epithelial A549 cells with vitamin C abrogated CSE-induced I-B degradation thereby affecting the nuclear translocation of c-Rel and subsequent NF-B activation. Besides, the in vitro observations are also corroborated with in vivo animal data from CS-exposed guinea pig that were either treated or not treated with vitamin C. Like humans, guinea pigs cannot synthesize vitamin C and this inability makes it a more appropriate animal model compared to mouse for such studies. The capability of vitamin C to prevent CS-induced NF-B activation even in the in vivo guinea pig model bolster the therapeutic potential of vitamin C against CS-induced NF-B activation and increases the importance of this antioxidant in the physiological system. Vitamin C has important role in metabolic processes, particularly it is important in blood and the fluids present in the extracellular space, where antioxidant enzymes are absent or present only in small quantities. Therefore, dietary supplementation of vitamin C is required for animals like human and guinea pigs that are incapable of synthesizing it. Our results in guinea pig model reveals that a dose of 1 mg/day of vitamin C is not sufficient to combat the CS-induced NF-B activation, rather a higher dose of 5 mg/day is required for this purpose. Based on this result in guinea pig, it can be suggested that for humans a regular intake of around 15 mg of vitamin C/kg body weight/day may provide protection against CS-induced NF-B activation. Our result shows that vitamin C pretreatment helps to reduce the level of ROS generated by CSE, thereby limiting the level of oxidative stress triggered by CSE. However it is not clear whether this prevention of NF-B activation by vitamin C is exclusively due to its antioxidant property or it has the ability to modulate signaling pathways independent of its antioxidant property. Quitting smoking is the best way of protecting oneself from the threat of CS-induced inflammatory diseases. However different approaches for cessation of smoking have limited success due to the highly addictive nature of the habit. In addition, therapeutic agents, such as nicotine patches, nicotine gum, bupropion and varenicline, have also been introduced to reduce the severity of withdrawal symptoms and cravings. However, these too are not free from side effects (Altintas et al., 2013; Einarson and Einarson, 1997; Gemenetzidis et al., 2009; Morales-Suárez-Varela et al., 2006). To this end, vitamin C may provide an alternative option to prevent the menace of CS-induced cellular damages and subsequent life threatening diseases. 5. Conclusion The current study demonstrates that vitamin C, by impairing CS-induced degradation of I-B and subsequent nuclear translocation of c-Rel, prevents CS(E)-induced NF-B activation in alveolar
5
epithelial cells. Since NF-B plays vital role in inflammation and alveolar epithelial cells are major contributor toward developing pulmonary pathogenesis, vitamin C could potentially be an effective preventive agent against CS-induced lung inflammatory diseases for the better management of public health. Competing interest The authors declare no conflict of interest. Acknowledgements This work is funded by University Grant Commission, Government of India [Sanction number: 32-591/2006(SR)]. BD is supported with a fellowship funded by University of Calcutta. References Adams, J., 2001. Proteasome inhibition in cancer: development of PS-341. Seminars in Oncology 28, 613–619. Altintas, N.D., Izdes, S., Yucel, S., Suher, M., Dilek, I., 2013. A case of thrombotic thrombocytopenic purpura associated with bupropion. International Journal of Clinical Pharmacology and Therapeutics 51, 224–227. Banerjee, S., Maity, P., Mukherjee, S., Sil, A.K., Panda, K., Chattopadhyay, D., Chatterjee, I.B., 2007. Black tea prevents cigarette smoke-induced apoptosis and lung damage. Journal of Inflammation (London) 4, 3. Bernard, D., Monte, D., Vandenbunder, B., Abbadie, C., 2002. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene 21, 4392–4402. Bhalla, D.K., Hirata, F., Rishi, A.K., Gairola, C.G., 2009. Cigarette smoke, inflammation, and lung injury: a mechanistic perspective. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 12, 45–64. Chaturvedi, M.M., Mukhopadhyay, A., Aggarwal, B.B., 2000. Assay for redox-sensitive transcription factor. Methods in Enzymology 319, 585–602. Chiu, B.C., Lynch, C.F., Cerhan, J.R., Cantor, K.P., 2001. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Annals of Epidemiology 11, 28–37. Einarson, T.R., Einarson, A., 1997. Hiccups following nicotine gum use. Annals of Pharmacotherapy 31, 1263–1264. Frei, B., England, L., Ames, B.N., 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences of the United States of America 86, 6377–6381. Gemenetzidis, E., Bose, A., Riaz, A.M., Chaplin, T., Young, B.D., Ali, M., Sugden, D., Thurlow, J.K., Cheong, S.C., Teo, S.H., Wan, H., Waseem, A., Parkinson, E.K., Fortune, F., Teh, M.T., 2009. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS ONE 4, e4849. Ghosh, S., Karin, M., 2002. Missing pieces in the N F-kappaB puzzle. Cell 109 Suppl., S81–S96. Hayden, M.S., Ghosh, S., 2004. Signaling to N F-kappaB. Genes and Development 18, 2195–2224. Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., Adams, J., Anderson, K.C., 2002. NF-kappa B as a therapeutic target in multiple myeloma. Journal of Biological Chemistry 277, 16639–16647. Karin, M., Yamamoto, Y., Wang, Q.M., 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nature Reviews Drug Discovery 3, 17–26. Maity, P.C., Bhattacharjee, S., Majumdar, S., Sil, A.K., 2009. Potentiation by cigarette smoke of macrophage function against Leishmania donovani infection. Inflammation Research 58, 22–29. Maity, P.C., Ray, T., Das, B., Sil, A.K., 2012. IKK-I-xB-c-Rel/p50: a new axis of NF-KB activationin lung epithelial cells. Oncogenesis 1, 1–7. Majumdar, S., Lamothe, B., Aggarwal, B.B., 2002. Thalidomide suppresses NFkappa B activation induced by TNF and H2 O2 , but not that activated by ceramide, lipopolysaccharides, or phorbol ester. Journal of Immunology 168, 2644–2651. Morales-Suárez-Varela, M.M., Bille, C., Christensen, K., Olsen, J., 2006. Smoking habits, nicotine use, and congenital malformations. Obstetrics & Gynecology 107, 51–57. Pahl, H.L., 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853–6866. Rahman, A., Fazal, F., 2011. Blocking NF-B: an inflammatory issue. Proceedings of the American Thoracic Society 8, 497–503. Ray, T., Maity, P.C., Banerjee, S., Deb, S., Dasgupta, A.K., Sarkar, S., Sil, A.K., 2010. Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. Journal of Atherosclerosis and Thrombosis 17, 817–827.
Please cite this article in press as: Das, B., et al., Vitamin C forestalls cigarette smoke induced NF-B activation in alveolar epithelial cells. Toxicol. Lett. (2013), http://dx.doi.org/10.1016/j.toxlet.2013.04.009
297 298 299 300 301
302
303
304
305 306 307
308
309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369
G Model TOXLET 8291 1–6 6
370 371 372 373 374
ARTICLE IN PRESS B. Das et al. / Toxicology Letters xxx (2013) xxx–xxx
Silva Bezerra, F., Valenc¸a, S.S., Lanzetti, M., Pimenta, W.A., Castro, P., Gonc¸alves Koatz, V.L., Porto, L.C., 2006. Alpha-tocopherol and ascorbic acid supplementation reduced acute lung inflammatory response by cigarette smoke in mouse. Nutrition 22, 1192–1201. Tak, P.P., Firestein, G.S., 2001. NF-kappaB: a key role in inflammatory diseases. Journal of Clinical Investigation 107, 7–11.
Tharappel, J.C., Cholewa, J., Espandiari, P., Spear, B.T., Gairola, C.G., Glauert, H.P., 2010. Effects of cigarette smoke on the activation of oxidative stress-related transcription factors in female A/J mouse lung. Journal of Toxicology and Environmental Health. Part A 73, 1288–1297. Vassallo, R., Ryu, J.H., 2008. Tobacco smoke-related diffuse lung diseases. Seminars in Respiratory and Critical Care Medicine 29, 643–650.
Please cite this article in press as: Das, B., et al., Vitamin C forestalls cigarette smoke induced NF-B activation in alveolar epithelial cells. Toxicol. Lett. (2013), http://dx.doi.org/10.1016/j.toxlet.2013.04.009
375 376 377 378 379 380